Product Information

METHYLPREDNISOLONE 4 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1240 per EA under NDC 68382091601. Its NADAC has been published 415 times since Sep 12, 2018.

FDA first approved this application on Apr 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

METHYLPREDNISOLONE 4 MG TABLET

methylprednisolone
$0.1240per EA

Strength

4 mg/1

NDC

68382091601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

METHYLPREDNISOLONE

Approval Type

Generic (ANDA)

FDA Application

ANDA206751

FDA Approved

4/23/2018

TE Code

AB

On Market Since

5/1/2018

Pharmacological Classes

Corticosteroid Hormone Receptor Agonists
Corticosteroid

Price Statistics

The NADAC for METHYLPREDNISOLONE 4 MG TABLET has been published 415 times since Sep 12, 2018, and over the history we have for it it has declined 59.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1240 per EA
All-time high$0.3083 (Feb 13, 2019)
All-time low$0.1105 (Nov 20, 2024)
52-week high$0.1606
52-week low$0.1211
Median price$0.1693
Average price$0.1877
Largest weekly change-32.7% (Apr 17, 2024)
Weeks tracked415
Tracking sinceSep 12, 2018

Price History

1W

-5.1%

1M

-5.1%

3M

-0.2%

6M

-11.6%

1Y

-22.8%

3Y

-21.5%

5Y

-37.9%

All

-59.4%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHYLPREDNISOLONE 4 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPREDNISOLONE 4 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1240 per EA (NDC 68382091601), effective Aug 19, 2026.

How has the price of METHYLPREDNISOLONE 4 MG TABLET changed over time?

Over the history we have for it, the NADAC for METHYLPREDNISOLONE 4 MG TABLET has declined 59.4%. It has been tracked across 415 weekly CMS publications since Sep 12, 2018.

What are the highest and lowest recorded NADAC prices for METHYLPREDNISOLONE 4 MG TABLET?

Since Sep 12, 2018, the NADAC for METHYLPREDNISOLONE 4 MG TABLET has ranged from a low of $0.1105 (Nov 20, 2024) to a high of $0.3083 (Feb 13, 2019), with a median of $0.1693 per EA.

Are there cheaper alternatives to METHYLPREDNISOLONE 4 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLPREDNISOLONE 4 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures METHYLPREDNISOLONE 4 MG TABLET?

METHYLPREDNISOLONE 4 MG TABLET (NDC 68382091601) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.